# Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children

> **NCT02707523** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 48 (actual)

## Conditions studied

- Respiratory Syncytial Virus

## Interventions

- **DRUG:** Azithromycin 10 mg
- **DRUG:** Azithromycin 20mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02707523
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-01
- **Primary completion:** 2019-02-06
- **Final completion:** 2020-06-20
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02707523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02707523, "Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02707523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*